Fighting the Flu: What You Need to Know about Seasonal Influenza

Article

This video explains the advantages and limitations of rapid testing for influenza in the point-of-care setting.

This video CME program explains the advantages (rapid and specific) and limitations (low sensitivity in some settings) of rapid testing for influenza in the point-of-care setting, identifies recent changes in influenza vaccination recommendations for infants and children (live-attenuated intranasal vaccine approved for younger groups of children), and describes the treatment of influenza disease using currently recommended medications that have activity against circulating strains of influenza.

Click here to access this third-party resource.

Related Videos
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
© 2024 MJH Life Sciences

All rights reserved.